Seyed Ramin Radfar
Overview
Explore the profile of Seyed Ramin Radfar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Radfar N, Radfar S, Mohammadi F, Azimi A, Amirkafi A, Tehrani-Banihashemi A
Front Psychiatry
. 2023 Jun;
14:1139307.
PMID: 37304442
Introduction: Compulsory treatment has decades of history in Iran; both before and after the Islamic Revolution, but there are many debates regarding its efficacy and effectiveness. Retention Rate is one...
2.
Farhoudian A, Radfar S
Am J Public Health
. 2022 Mar;
112(S2):S133-S135.
PMID: 35349327
No abstract available.
3.
Farhoudian A, Radfar S, Mohaddes Ardabili H, Rafei P, Ebrahimi M, Zonoozi A, et al.
Front Psychiatry
. 2021 Aug;
12:646206.
PMID: 34421664
COVID-19 has infected more than 77 million people worldwide and impacted the lives of many more, with a particularly devastating impact on vulnerable populations, including people with substance use disorders...
4.
Radfar S, De Jong C, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, et al.
Front Psychiatry
. 2021 May;
12:639393.
PMID: 34025471
The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. One week after...
5.
Radfar S, Nematollahi P, Tayeri K, Dehghan H, Janani M, Higgs P, et al.
Drug Alcohol Rev
. 2020 Dec;
40(4):572-579.
PMID: 33345378
Introduction: Iran has an human immunodeficiency viruses (HIV) epidemic that is concentrated among people who inject drugs (PWID), who have higher risks of progression from latent tuberculosis infection (LTBI) to...
6.
Baldacchino A, Radfar S, De Jong C, Rafei P, Yunesian M, Gerra G, et al.
Basic Clin Neurosci
. 2020 Aug;
11(2):155-162.
PMID: 32855774
Introduction: As one of the major health problems in the present century, the COVID-19 pandemic affected all parts of the global communities and the health of substance users are potentially...
7.
Farhoudian A, Baldacchino A, Clark N, Gerra G, Ekhtiari H, Dom G, et al.
Basic Clin Neurosci
. 2020 Aug;
11(2):133-150.
PMID: 32855772
Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized...
8.
Alavi M, Moghanibashi-Mansourieh A, Radfar S, Alizadeh S, Bahramabadian F, Esmizade S, et al.
Int J Drug Policy
. 2020 Aug;
93:102908.
PMID: 32819776
An unprecedented public health crisis confronts the world. Iran is among the hardest-hit countries, where effects of the COVID-19 pandemic are stretched across society and felt by the most marginalised...
9.
Ekhtiari H, Noroozi A, Farhoudian A, Radfar S, Hajebi A, Sefatian S, et al.
Addiction
. 2019 Nov;
115(7):1395-1403.
PMID: 31737965
Backgrounds And Aims: Iran has 2.1 and 1.8% of its 15-64-year-old population living with illicit substance and opioid use disorders, respectively. To address these problems, Iran has been developing a...
10.
Moradi G, Hajarizadeh B, Rahmani K, Mohamadi-Bolbanabad A, Darvishi S, Zareie B, et al.
Int J Drug Policy
. 2019 Oct;
73:129-134.
PMID: 31654935
Background: Stimulants substances use, particularly methamphetamine use, is increasing globally, including in Iran. This study assessed the drug use and risk behaviour profile, and prevalence of HIV, hepatitis C virus...